These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 33938182)

  • 1. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
    Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
    Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.
    Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE
    Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR
    Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Geographical variation of asthma prevalence among Mexican children during the COVID-19 pandemic].
    Bedolla-Pulido TR; Morales-Romero J; Bedolla-Pulido A; Meza-López C; Valdez-Soto JA; Bedolla-Barajas M
    Rev Alerg Mex; 2023 Apr; 69(4):164-170. PubMed ID: 37218044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Susceptibility in Bronchial Asthma.
    Green I; Merzon E; Vinker S; Golan-Cohen A; Magen E
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):684-692.e1. PubMed ID: 33242628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
    Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
    Chung E; Chow EJ; Wilcox NC; Burstein R; Brandstetter E; Han PD; Fay K; Pfau B; Adler A; Lacombe K; Lockwood CM; Uyeki TM; Shendure J; Duchin JS; Rieder MJ; Nickerson DA; Boeckh M; Famulare M; Hughes JP; Starita LM; Bedford T; Englund JA; Chu HY
    JAMA Pediatr; 2021 Oct; 175(10):e212025. PubMed ID: 34115094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study.
    Brotons P; Jordan I; Bassat Q; Henares D; Fernandez de Sevilla M; Ajanovic S; Redin A; Fumado V; Baro B; Claverol J; Varo R; Cuadras D; Hecht J; Barrabeig I; Garcia-Garcia JJ; Launes C; Muñoz-Almagro C
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False negative rate of COVID-19 PCR testing: a discordant testing analysis.
    Kanji JN; Zelyas N; MacDonald C; Pabbaraju K; Khan MN; Prasad A; Hu J; Diggle M; Berenger BM; Tipples G
    Virol J; 2021 Jan; 18(1):13. PubMed ID: 33422083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.
    O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S
    CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
    Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.
    Mangamba LE; Sike CIM; Tochie JN; Dalle GN; Nkouagmi N; Balkissou AD; Bille BE; Ngahane BHM; Moukoko CEE
    Pan Afr Med J; 2023; 44():204. PubMed ID: 37484595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.